siRNA Transfection in 3D Cell Culture and Organoids: What’s Different?
Transfecting siRNA into cells grown in three-dimensional (3D) culture systems or organoids introduces unique challenges compared to conventional two-dimensional (2D) monolayer cultures. While 2D cultures offer uniform access to transfection reagents and facilitate standardized protocols, 3D models more accurately mimic the architecture, extracellular matrix interactions, and diffusion barriers present in vivo.
In 3D cultures and organoids, cells are embedded in dense matrices or aggregate into spheroids, which can restrict the penetration of transfection complexes. This physical barrier limits siRNA accessibility, resulting in lower delivery efficiency and heterogeneous knockdown across the cell population. To overcome this, transfection protocols must be adapted to ensure deeper reagent diffusion. Strategies include extending incubation times, modifying reagent formulations, or applying electroporation to intact 3D structures.
Another key consideration is the use of serum and matrix components, which may interfere with complex formation or stability. Additionally, cell viability is more sensitive in 3D systems due to the compact architecture and limited nutrient diffusion, so careful optimization of siRNA dose and transfection conditions is required to maintain structure integrity and function.
Assessing gene silencing in 3D models may require dissociating organoids for single-cell analysis or using whole-mount staining and imaging techniques. Despite the added complexity, siRNA transfection in 3D systems enables more physiologically relevant insights into gene function, drug response, and disease mechanisms.
References: Altogen.com Altogenlabs.com